Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect on HbA1c of the Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland

NCT06268821 is registered in ClinicalTrials.gov with Abbott Diabetes Care as lead sponsor.

NCT NCT06268821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06268821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect on HbA1c of the Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland
Lead sponsor
Abbott Diabetes Care
Phase
Not applicable
Overall status
Terminated
Start date
April 2, 2024
Completion date
July 12, 2024
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes treated with insulin